Last Price Today's Change   Day's Range   Trading Volume
0.48   +0.005 (1.05%)  0.46 - 0.49  3,178,500
Analyze this stock with MQ Trader system


Market Cap: 652 Million
NOSH: 1,358 Million
Avg Volume (4 weeks):4,611,250
4 Weeks Range:0.40 - 0.585
4 Weeks Price Volatility (%):
52 Weeks Range:0.24 - 0.76
52 Weeks Price Volatility (%):
Average Price Target: 0.28
Price Target Upside/Downside: -0.20
Stamp duty exempted for year 2020

Financial Highlight

Latest Quarter | Ann. Date 30-Jun-2020 [#4]  |  28-Aug-2020
Next QR | Est. Ann. Date: 30-Sep-2020  |  29-Nov-2020
T4Q P/E | EY: -305.83  |  -0.33%
T4Q DY | Payout %: 0.00%  |  - %
T4Q NAPS | P/NAPS: 0.8114  |  0.59
T4Q NP Margin | ROE: 1.31%  |  -0.19%


Date Subject
12-Aug-2020 PublicInvest Research Headlines - 12 Aug 2020
12-Aug-2020 Four more companies plan to join the rubber glove makers club
29-Jul-2020 [转贴] [TITIJAYA LAND BHD:将通过马来亚银行的活动来吸引潜在的购房者,重点推广Rent-To-Own (“RTO”),即HouzKey的营销计划] - James的股票投资James Share Investing
20-Jul-2020 Property & REIT - Still lacking catalyst
27-May-2020 Titijaya Land- Stay focused and remain prudent
14-May-2020 PublicInvest Research Headlines - 14 May 2020
30-Apr-2020 Titijaya Land - Collaboration with China-based Sinopharm
30-Apr-2020 PublicInvest Research Headlines - 30 Apr 2020
09-Apr-2020 Property & REIT - Near-term outlook uncertain; steps up social responsibility
12-Mar-2020 [转贴] [TITIJAYA LAND BHD:收入下降的部分原因是过去几年的销售下降以及没有如上一财政期间从强制性土地出售获得的一次性补偿收入] - James的股票投资James Share Investing
04-Mar-2020 Property & REIT - 4QCY19 largely in line; REITs continue to be resilient
02-Mar-2020 Titijaya Land - A soft patch in 1HFY20, earnings to improve in 2HFY20
22-Jan-2020 Titijaya Land - Expect higher revenue recognition in coming quarters
17-Dec-2019 PublicInvest Research Headlines - 17 Dec 2019
17-Dec-2019 Mplus Market Pulse - Mild Gains Ahead
02-Dec-2019 Titijaya Land Berhad - 1QFY20: Off to a Tepid Start
02-Dec-2019 TITIJAYA LAND - A Soft Patch in 1QFY20
02-Dec-2019 Titijaya Land Berhad - 1QFY20: Off to a Tepid Start
25-Sep-2019 Mplus Market Pulse - 25 Sep 2019

Business Background

Titijaya Land Bhd, together with its subsidiaries, is engaged in property development. It develops housing and commercial units for sales to house and office building purchasers.
Trade this stock for as low as 0.05% brokerage. Find out more.

  2 people like this.
Vanbasten Think of this as silicon titts
15/09/2020 11:34 PM
ITCHYLEG buy titijaya pa
loss 20% gain 2000%+
16/09/2020 2:33 AM
Snowthief Whoever collecting since last week already paper gain by now.. but do keep holding until vaccine reach your doorstep. Imagine that time, we might have 4 titans too, you name them.. like 4 gloves...
Have faith in our friendship. Friendship forever~
16/09/2020 8:58 AM
meerkat0078 Regaining strength... Time to acquire.
16/09/2020 10:59 AM
High5 In coronavirus vaccine race, China inoculates thousands before trials are completed

By David Stanway, Miyoung Kim | Reuters | 2020-09-16 12:53:02

SHANGHAI/SINGAPORE (Sep 16): China is inoculating tens of thousands of its citizens with experimental coronavirus vaccines and attracting international interest in their development, despite expert concerns over the safety of drugs that have not completed standard testing.
China launched a vaccine emergency use programme in July, offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech. A fourth COVID-19 vaccine being developed by CanSino Biologics was approved for use by the Chinese military in June.
Aiming to protect essential workers and reduce the likelihood of a resurgence, the vaccines are also grabbing attention in the global scramble by governments to secure supplies, potentially helping reframe China’s perceived role in the pandemic.
Beijing has not released official data on the uptake in domestic targeted groups, which include medical, transport and food market workers.
But China National Biotec Group (CNBG), the Sinopharm unit developing two of the emergency use vaccines, and Sinovac have confirmed that at least tens of thousands of people have been inoculated. Additionally, CNBG said it had given hundreds of thousands of doses; one of its vaccines requires an individual receive two or three shots to be inoculated.
Beijing has engaged a public, top-down approach to endorse the experimental vaccines and foster community support. Among those lining up for shots early on were the chief executives of Sinovac and Sinopharm and the military’s research chief.
The chief biosafety expert at the Chinese Center for Disease Control and Prevention (CDC) revealed this week that she too had been injected in April as she announced the potential that at least some of the vaccines would be ready for public use as early as November.
“So far, among the people who who were vaccinated, no one has been sick with the disease,” Guizhen Wu said on state TV. “So far, (the vaccination scheme) works very well. No side effect occurred.”
Wu’s comments were broadly in line with comments by CNBG last week that none of tens of thousands of people who travelled to high-risk countries and regions after being vaccinated had been infected, and there was “no case of obvious adverse reaction”.


China’s approach runs counter to that of many Western countries, where experts have warned against authorizing the emergency use of vaccines that have not completed testing, citing a lack of understanding about longer-term efficacy and potential side effects.
Anna Durbin, a vaccine researcher at Johns Hopkins University, described China’s emergency use programme as “very problematic,” saying it was impossible to judge efficacy without a clinical trial standard control group.
“You’re vaccinating people and you don’t know if it’s going to protect them,” Durbin told Reuters, adding recipients of the experimental vaccines could eschew other protective measures.
Vaccine safety came into sharp focus last week when AstraZeneca Plc paused late-stage clinical trials of its COVID-19 vaccine, one of the most advanced in development.
The company resumed British trials over the weekend after receiving the green light from safety watchdogs, and, along with other leading Western vaccine makers has pledged to uphold scientific study standards and reject any political pressure to rush the process.
Russia is one of the few other countries to authorise the use of an experimental vaccine, making its own “Sputnik V” vaccine mandatory for certain groups including teachers. India is considering emergency authorization for a vaccine, particularly for the elderly and people in high-risk workplaces.


The UAE authorized the emergency use of a Sinopharm vaccine this week, the first international emergency clearance for one of China’s vaccines, just six weeks after human trials began in the Gulf Arab state. UAE officials reported mild and expected side effects, but no severe side effects, during those trials.
CanSino has been approached by several countries, a source familiar with the discussions told Reuters, adding the military’s approval helped attract foreign interest. The person declined to name the countries engaged in talks.
CanSino, which has trials planned in Pakistan and Russia for the vaccine developed with China’s military research unit, did not respond to a request for comment.
Zhang Yuntao, CNBG vice president told Reuters his company has received interest from foreign countries to buy about 500 million doses of its experimental vaccine.
“China clearly wants to reorient that narrative in a way that it is viewed as a solution rather than a cause of the pandemic,” Yanzhong Huang, Senior Fellow for Global Health, Council on Foreign Relations, a U.S.-based think tank.
“That narr
16/09/2020 4:35 PM
Friendship If UAE’s Ministry of Health approves the vaccine, it means Sinopharm vaccine are safe and soon it will receive WHO endorsement too!

There are so many thousands of volunteers under the vaccine trial programs in Middle East and so far no negative reports at all.

This shows Inactivated or Attenuated Coronavirus Vaccines are still the most efficient and safest approach!

Matter of time for Sinopharm to receive final approval from the authority!
16/09/2020 5:58 PM
skng60 https://youtu.be/EnJ3ZUy5P2w
16/09/2020 9:56 PM
fhis Maybe limit up today. Let’s hope.
17/09/2020 3:02 AM
tan1868 Slow and steady! Vol increasing, good sign.
Will Pecut with any announcements!
17/09/2020 9:40 AM
tank0210 https://www.google.com.my/amp/s/fortune.com/2020/09/16/china-covid-vaccine-emergency-use-approval-uae-global-sinopharm/amp/
17/09/2020 6:20 PM
fhis Engine started?
18/09/2020 3:03 PM
Friendship Be patient, Titijaya will be Top Glove of vaccine play soon
18/09/2020 3:17 PM
salman https://www.theborneopost.com/2020/09/18/mma-health-ministry-should-explain-why-msia-has-not-signed-up-for-covid-19-vaccine-plan/
18/09/2020 4:01 PM
salman Almost every single country in the world has now signed up to be part of vaccine initiative, except for Malaysia
18/09/2020 4:13 PM
salman https://www.freemalaysiatoday.com/category/nation/2020/09/18/be-transparent-over-covid-19-vaccine-plans-mma-tells-putrajaya/
18/09/2020 4:15 PM
scenery LOL...
18/09/2020 11:04 PM
Newbie0001 titijaya sign on behalf....hehehehee
19/09/2020 8:31 AM
Zainuddin Hussien 8.00pm news says, malaysia government will sign the covax agreement..this is a good news for titijaya
19/09/2020 8:07 PM
Friendship Great news!

Malaysia can access to China Sinopharm Vaccine soon!
19/09/2020 8:10 PM
ITCHYLEG wait for the EGM
19/09/2020 8:35 PM
Newbie0001 Yes...Titijaya can play its role now...kick off vaccine business with Sinopharm .
19/09/2020 8:36 PM
Friendship Malaysia government wants to make Malaysia the vaccine hub for South East Asia!

Titijaya Medical can partner with Sinopharm to build the hub! Proud to be Anak Malaysia!
19/09/2020 8:43 PM
IXCCXXXIX https://www.reuters.com/article/us-health-coronavirus-vaccine-china-idUSKCN24O0PM
19/09/2020 11:24 PM
IXCCXXXIX https://www.trtworld.com/life/china-s-sinopharm-covid-19-vaccine-to-be-available-at-end-of-2020-38989
19/09/2020 11:26 PM
IXCCXXXIX Load up & be ready for d' day!
19/09/2020 11:28 PM
20/09/2020 12:17 AM
menort "High percentage of retailer who think they can out-smart the stock market and enter lose making penny stock and dream to become a millionaire, majority will lose big amount of money compare to the retailer who put money on profit making company that its share price Rm1 and above counter"

Want to go vaccine counter? go to genuine vaccine counter example Pharmaniaga and Duopharma. Malaysia gave licence only to Pharmaniaga and Duopharma to distribute covid19. Dont act smart and think Bintai can sell vaccine it will never happen in Million years in Malaysia. Never touch any lose making penny stock counter who try to ride on vaccine theme.

Want to invest on glove counter? invest only on genuine glove counter Top glove, Supermax, Hartalega, Kossan, Ruberex, Comfort, Careplus, Hlt and LKL.

Never touch any other than above counter.
20/09/2020 12:53 AM
Snowthief Vaccine from Sinopharm having more potential since our neighborhood abangadik Indonesia also testing on Sinopharm. You know Malaysia! Hahahaha limit up Monday!!
20/09/2020 8:18 AM
Snowthief 我国参与COVAX疫苗


20/09/2020 8:31 AM
Friendship There are over 170 countries in covax agreement but only 2 phase III vaccines are participating in it. In other words, Malaysia will still rely more on vaccines from Sinopharm, China for better supply quantity and also better pricing.

It’ll be better pricing if Titijaya Medical can set up the purpose built medical base here in Malaysia partnering with Sinopharm as this will help to increase the production capacity. Go and read the agreement Titijaya sign with Sinopharm.

Strategic Collaboration Agreement I

TRSB and SMEQ shall be exclusively responsible and to develop the New Business as set out in the Strategic Collaboration Agreement I in their specified territory as follows:-

TRSB: Malaysia, Singapore, Indonesia, Thailand and Australia SMEQ: China

(i) TRSB's responsibility and contribution
TRSB shall be responsible in the area of medical related real estate by providing infrastructures, land and facilities for the medical operators recommended by Sinopharm Group or SMEQ pertaining to the New Business.

(ii) SMEQ's responsibility and contribution
SMEQ undertakes to supply the medical and hospital equipment and products under the New Business as set out in the Strategic Collaboration Agreement I.

Strategic Collaboration Agreement II

(i) TRSB's responsibility and contribution

TRSB undertakes to provide funding to meet the financing conditions for the construction base and be responsible for the related development and construction conditions of the construction base for the purpose of the New Business as set out in Strategic Collaboration Agreement II.

(ii) SINOMACH's responsibility and contribution

SINOMACH undertakes to assist TRSB in sourcing for funding, and to provide resources in any manners, at the construction base, for the supply of equipment, technological and technical support for the New Business.
20/09/2020 9:21 AM
Friendship Read carefully between the lines

It already give u big hint that Sinopharm likely to partner with Titijaya to build additional production line here in Malaysia to supply the vaccines to South East Asia.
20/09/2020 9:27 AM
Newbie0001 Yes Friendship, thanks for your great news!
So far very positive and fantastic progress for Titijaya to venture into vaccines business via collaboration with Sinopharm
20/09/2020 9:32 AM
KenKen84 Confirm deal with chines company . Either Sinopharm,Sinovac or Cansiro ! 33.33%
20/09/2020 12:31 PM
Friendship Titijaya Medical has the proper agreement and financial depth to partner with China State owned pharma like Sinopharm to set up the vaccine hub
20/09/2020 12:36 PM
MacamYes Tititjaya looking good next week trade. don't miss the early train ya!
20/09/2020 3:28 PM
menort https://9shares.my/the-edge揭秘─21家仙股股东董事成员或同批人/
20/09/2020 5:26 PM
Friendship Titijaya is not a speculative counter and it’s not related to any of the companies mentioned in the article
20/09/2020 5:44 PM
tan1868 Bad market but Titi firming, Sinopharm vaccines play brewing!
22/09/2020 9:33 AM
Cheah5555 Waiting for more announcements on how the partnership works, it may or may not involve vaccines
22/09/2020 10:59 AM
Newbie0001 Under the agreement, Titijaya said TRSB and SMEQ will collaborate to develop the business by leveraging on the supply and value chain of Sinopharm Group and SMEQ in China, as well as the networks of TRSB and Sinopharm Group.

Supplier and value chain of Sinopharm group shall included vaccine from Sinopharm once the covid 19 vaccine was ready
22/09/2020 12:49 PM
Newbie0001 If not Titijaya, it is very weird that Sinopharm has to find another company again to collaborate for distribute vaccine from Sinopharm, currently covid test kids already through Titijaya, logically vaccine shall be included also.
22/09/2020 1:06 PM
Friendship I urge you guys to trust Tan Sri Lim and you all will be well rewarded once announcement is out, which is very soon!
22/09/2020 1:12 PM
salman Bintai already 0.79 on vaccine news today
22/09/2020 1:48 PM
huntertee Wait till hair turned white.. haha
22/09/2020 1:50 PM
Friendship It’s all about art of war

Those fake ones will appear as real to con people

Those real ones will stay low profile for more accumulation
22/09/2020 2:42 PM
Friendship For Titijaya, the strategy is simple, just buy whenever it drops and keep until announcements

Please don’t buy contra or plan to trade for 1-2 cents gain
22/09/2020 2:56 PM
Newbie0001 Yes friendship,I think so, very soon, is coming.
22/09/2020 2:56 PM
Newbie0001 Bintai from year lowest at RM 0.04 to RM0.725, almost increased 1,700%......Titijaya will be the next
22/09/2020 3:01 PM
fhis Titijaya starts to move, buy in
22/09/2020 4:30 PM
salman Bintai limit up today 0.935
22/09/2020 4:33 PM

I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Earn MQ Points while trading with MQ Traders Group
MQ Affiliate
Earn side income from MQ Affiliate Program

534  354  600  593 

Top 10 Active Counters
 BINTAI 0.775+0.14 
 NETX 0.010.00 
 MMAG-WB 0.195-0.15 
 SOLUTN 0.69+0.05 
 KANGER 0.31+0.025 
 DGSB 0.19+0.015 
 LAMBO 0.040.00 
 PASUKGB 0.125+0.02 
 NOTION 1.14+0.14 
 XOX 0.1850.00 


1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!